company_name,company_overview,contact_name,contact_role,contact_linkedin,contact_email,subject,body,generated_at
Celmatix,"Celmatix is a preclinical-stage biotechnology company focused on developing novel therapeutics for women's health, including polycystic ovary syndrome (PCOS) and infertility. Based in New York City and Cambridge, MA, Celmatix aims to leverage genetic insights to create targeted treatments for these complex conditions.",Piraye Beim,Founder and CEO at Celmatix Therapeutics,https://www.linkedin.com/in/pirayebeim,,Revitalizing Women's Health: A New Approach?,"Dear Piraye, I've been deeply inspired by Celmatix's commitment to transforming women's health, particularly your innovative work on PCOS and infertility. At Convexia Bio, we share a similar passion for pushing the boundaries of medicine, using AI to rescue and repurpose failed or dormant drug assets. Given the complexity of conditions like PCOS, our AI-powered models could offer new insights into dose optimization, patient stratification, and combination therapy design, potentially breathing new life into trials that didn't meet endpoints. Could there be an opportunity to explore how our technologies might align, especially for assets looking for a second chance? Warm regards, Ayaan",2025-11-17 22:58:09.903527
Celmatix,"Celmatix is a preclinical-stage biotechnology company focused on developing novel therapeutics for women's health, including polycystic ovary syndrome (PCOS) and infertility. Based in New York City and Cambridge, MA, Celmatix aims to leverage genetic insights to create targeted treatments for these complex conditions.","Karen Hunter Cohn, PhD",Celmatix,https://www.linkedin.com/in/karenhcohn,,Revitalizing Women's Health Innovations with AI,"Dear Dr. Cohn, Your groundbreaking work at Celmatix, especially around PCOS and infertility, caught my eye. It's clear you're pushing the boundaries in women's health, a mission we deeply respect at Convexia Bio. We specialize in leveraging AI to breathe new life into challenging drug assets, focusing on dose optimization, patient stratification, and more. Given the complexity of conditions like PCOS, I wonder if there's untapped potential in your pipeline that our AI models could unlock. Would you be open to a brief chat about your current challenges and explore if there's a fit? Warm regards, Ayaan",2025-11-17 22:58:15.248310
Celmatix,"Celmatix is a preclinical-stage biotechnology company focused on developing novel therapeutics for women's health, including polycystic ovary syndrome (PCOS) and infertility. Based in New York City and Cambridge, MA, Celmatix aims to leverage genetic insights to create targeted treatments for these complex conditions.",Rich Hofbauer,Founder | Investor | Building Companies & ...,https://www.linkedin.com/in/rich-hofbauer-7362134,,Revolutionizing Women's Health Together?,"Hi Rich, I've been following Celmatix's innovative approach to tackling PCOS and infertility, and I'm genuinely impressed by the strides you're making in women's health. At Convexia Bio, we specialize in leveraging AI to breathe new life into challenging drug assets, focusing on dose optimization, patient stratification, and more. Given the complexity of conditions like PCOS, I believe there's a unique opportunity for us to explore how our AI models could potentially enhance your current or future projects. Would you be open to a brief chat to discuss any assets that might benefit from our technology? I'm all about ensuring meaningful progress in healthcare, especially in areas as impactful as yours. Best, Ayaan",2025-11-17 22:58:21.488318
Celmatix,"Celmatix is a preclinical-stage biotechnology company focused on developing novel therapeutics for women's health, including polycystic ovary syndrome (PCOS) and infertility. Based in New York City and Cambridge, MA, Celmatix aims to leverage genetic insights to create targeted treatments for these complex conditions.","Rebecca Chodroff Foran, PhD","Senior Director, R&D, ...",https://www.linkedin.com/in/rebecca-chodroff-foran-phd-112aa21b,,Revolutionizing Women's Health Together?,"Dear Rebecca, I was truly inspired by Celmatix's innovative approach to tackling PCOS and infertility, areas that are close to our mission at Convexia Bio. We specialize in using AI to breathe new life into promising drug assets that haven't reached their full potential, focusing on dose optimization, patient stratification, and more. Given the complexity of women's health, I believe there's a unique opportunity for us to explore how our AI-powered models could help accelerate or revive some of Celmatix's assets. Would you be open to a brief chat to see if there's a fit? I'm all about meaningful collaborations that push the boundaries of what's possible in healthcare. Warm regards, Ayaan",2025-11-17 22:58:27.580003
Celmatix,"Celmatix is a preclinical-stage biotechnology company focused on developing novel therapeutics for women's health, including polycystic ovary syndrome (PCOS) and infertility. Based in New York City and Cambridge, MA, Celmatix aims to leverage genetic insights to create targeted treatments for these complex conditions.",Elizabeth (Ellie) Amador,Director of Clinical Research ...,https://www.linkedin.com/in/elizabeth-ellie-amador-555a8666,,Revolutionizing Women's Health Together?,"Hi Ellie, I've been deeply inspired by Celmatix's commitment to pioneering treatments for PCOS and infertility, areas where too many women face challenges. At Convexia Bio, we share your passion for transforming women's health. Leveraging AI, we specialize in rescuing drug assets that didn't initially meet endpoints, focusing on dose optimization, patient stratification, and more. Given the complexity of conditions like PCOS, I believe there's a unique opportunity for us to explore how any of Celmatix's dormant assets could be revitalized, potentially accelerating your path to impactful therapies. Would you be open to a brief chat about where our approaches might intersect? Warm regards, Ayaan",2025-11-17 22:58:33.562979
Spruce Biosciences,"Spruce Biosciences is a biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders, including polycystic ovary syndrome (PCOS). They are running clinical trials for a drug called tildacerfont aimed at treating PCOS.",Percival Barretto-Ko,Spruce Biosciences,https://www.linkedin.com/in/pbarrettoko,,Revolutionizing PCOS Treatment with AI?,"Hi Percival, I've been closely following Spruce Biosciences' journey, especially your innovative work on tildacerfont for PCOS. It's clear you're leading the charge in tackling rare endocrine disorders, a mission that resonates deeply with us at Convexia Bio. We specialize in leveraging AI to rescue and optimize drug assets, focusing on dose optimization, patient stratification, and more. Given the complexity of endocrine disorders and the unique challenges in drug development for conditions like PCOS, I believe there's a unique opportunity for us to explore how our AI-powered models could potentially enhance tildacerfont's clinical journey or revive other assets in your pipeline. Would you be open to a brief chat to see if there's a fit? Best, Ayaan",2025-11-17 22:58:39.773224
Spruce Biosciences,"Spruce Biosciences is a biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders, including polycystic ovary syndrome (PCOS). They are running clinical trials for a drug called tildacerfont aimed at treating PCOS.",Kirk Ways,Spruce Biosciences,https://www.linkedin.com/in/kirk-ways-b436a67,,Revolutionizing PCOS Treatment with AI?,"Hi Kirk, I've been following Spruce Biosciences' journey, particularly your innovative work on tildacerfont for PCOS. It's clear you're leading the charge in addressing unmet needs in endocrine disorders. At Convexia Bio, we specialize in leveraging AI to rescue and optimize drug assets, focusing on dose optimization, patient stratification, and more. Given the complexity of PCOS and the challenges in clinical trials, I wonder if there's an opportunity to explore how our AI models could further enhance tildacerfont's development or revive any stalled projects you're passionate about. Would you be open to a brief chat to see if there's a mutual fit? Best, Ayaan",2025-11-17 22:58:45.355511
Spruce Biosciences,"Spruce Biosciences is a biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders, including polycystic ovary syndrome (PCOS). They are running clinical trials for a drug called tildacerfont aimed at treating PCOS.",Mary Romeo,SPARK at Stanford,https://www.linkedin.com/in/marydromeo,,Revolutionizing PCOS Treatment with AI?,"Hi Mary, I've been closely following Spruce Biosciences' journey, especially your innovative work on tildacerfont for PCOS. It's clear your team is at the forefront of addressing unmet needs in endocrine disorders. At Convexia Bio, we leverage AI-powered models to help biotechs like yours optimize dosing, stratify patients, and design combination therapies, potentially rescuing or enhancing drug assets. Given the complexity of PCOS and the challenges in clinical trials, I wonder if there's an opportunity to explore how our AI could support tildacerfont's development. Would you be open to a brief chat about your goals and see if there's a fit? Best, Ayaan",2025-11-17 22:58:51.560372
Spruce Biosciences,"Spruce Biosciences is a biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders, including polycystic ovary syndrome (PCOS). They are running clinical trials for a drug called tildacerfont aimed at treating PCOS.","Alexis Howerton, Ph.D.",Founder/CEO,https://www.linkedin.com/in/alexis-howerton-ph-d-7839076b,,Revolutionizing PCOS Treatment with AI?,"Hi Alexis, I've been following Spruce Biosciences' journey, particularly your innovative work on tildacerfont for PCOS. It's clear you're leading the charge in addressing unmet needs in endocrine disorders. At Convexia Bio, we leverage AI to breathe new life into promising drug assets, focusing on dose optimization, patient stratification, and more. Given the complexity of PCOS and the challenges in drug development, I wonder if there's an opportunity to explore how our AI models could further enhance tildacerfont's potential or revive any stalled assets you're passionate about. Would you be open to a brief chat about your goals and how we might support them? Best, Ayaan",2025-11-17 22:58:57.654417
Spruce Biosciences,"Spruce Biosciences is a biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders, including polycystic ovary syndrome (PCOS). They are running clinical trials for a drug called tildacerfont aimed at treating PCOS.",Mike Grey,Sorriso Pharmaceuticals,https://www.linkedin.com/in/mikegrey,,Revolutionizing PCOS Treatment with AI?,"Hi Mike, I've been closely following Spruce Biosciences' journey, especially your innovative work on tildacerfont for PCOS. It's clear you're leading the charge in tackling rare endocrine disorders, a mission we deeply respect at Convexia Bio. We specialize in leveraging AI to breathe new life into challenging drug assets, focusing on dose optimization, patient stratification, and more. Given the complexity of PCOS and the potential of tildacerfont, I wonder if there's an opportunity to explore how our AI models could further enhance its development or uncover new applications. Would you be open to a brief chat about your goals and see if there's a fit? Best, Ayaan",2025-11-17 22:59:03.955831
